Latest news and press releases about Bruker Corporation (BRKR): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies.
Price
| Price | $63.86 |
| Market Cap | $9.7B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 4.01 |
| EV / EBITDA | 46.23 |
| Dividend Yield | 0.32% |
Profitability
| Return on Equity | -2.92% |
| Return on Invested Capital | 2.56% |
| Return on Assets | -1.18% |
| Gross Margin | 46.69% |
| Operating Margin | 3.61% |
| Net Margin | -2.03% |
Related companies: BTSG · CHE · CRSP · GKOS · IRTC · KRYS · MMSI
Explore sector: Healthcare · Medical - Devices
More sections of BRKR: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks